Kee Chang Huang, M.D., Ph. D., was born in Canton, China, in 1917. He has been a Distinguished Professor at the University of Louisville. He attended Sun ...
Name / Title
Company / Classification
Phones & Addresses
Chang Huang President
Jas Corp All Other Miscellaneous Fabricated Metal Product Manufacturi · Plumbing Fixture Fitting and Trim Manufacturing
1970 Estelle Ln, Placentia, CA 92870 714 528-0828, 909 627-8222
Lyft
Engineering Manager and Infra Networking
Amazon Web Services Jun 2018 - Mar 2019
Software Development Manager
Bittitan May 2014 - May 2018
Director of Software Engineering
Lexisnexis Jan 2013 - May 2014
Consulting Software Engineer
Knowledge Mosaic Sep 2002 - Dec 2012
Chief Software Architect and Co-Founder
Education:
University of Georgia
Master of Science, Masters, Computer Science
Michigan State University
Master of Science, Masters, Mathematics
Skills:
C# Distributed Systems Sql Cloud Computing C++ Scrum Product Development Python Solr Microsoft Azure Microsoft Sql Server Cross Functional Team Leadership Lamp Mysql E Commerce Seo Windows Zookeeper Team Leadership Mentoring Distributed Computing Nlp Amazon Web Services Windows Azure Amazon S3 Security Architecture Design Software As A Service Agile Methodologies Enterprise Software Software Development Life Cycle Git Asp.net Databases Web Services Api Aws
Tianli Zheng - Culver City CA Chang Jiang Huang - Los Angeles CA
Assignee:
AmCyte, Inc. - Santa Monica CA
International Classification:
A61K 3539
US Classification:
424 937, 435347, 435373, 435375, 435402
Abstract:
This invention relates to the discovery that an intermediate, differentiated stage of pancreatic stem cells exist that can be propagated in a stable manner in successive serial passaging while maintaining insulin production in response to glucose. These cells are advantageous in that they are both expandable and stable in culture and can driven to late stage development, i. e. prototype islet cells. This invention further provides for culturing techniques that select for these intermediate differentiated stage cells and selectively eliminates early or late stage pancreatic cells.
Matt Losey - Rancho Cucamonga CA, US Melvin Khoo - San Gabriel CA, US Yohannes Desta - Arcadia CA, US Chang Huang - Arcadia CA, US
Assignee:
Advantest America, Inc - San Jose CA
International Classification:
G01R 31/00
US Classification:
32475603, 32475407, 32475403, 32475701, 32475702
Abstract:
A microelectronic contactor assembly can include a probe head having microelectronic contactors for contacting terminals of semiconductor devices to test the semiconductor devices. A stiffener assembly can provide mechanical support to microelectronic contactors and for connecting a probe card assembly to a prober machine. A stiffener assembly may include first and second stiffener bodies that are connected together at their central portions with adjustment mechanisms such as three differential screw mechanisms. A probe head may be attached to a first stiffener body at locations outside its central portion, while a prober machine may be attached to a second stiffener body at locations outside its central portion. The first and second stiffener bodies may have different coefficients of thermal expansion. The stiffener assembly allows for differential thermal expansion of various components of the microelectronic contactor assembly while minimizing accompanying dimensional distortion that could interfere with contacting the terminals of semiconductor devices.
Culturing Pancreatic Stem Cells Having A Specified, Intermediate Stage Of Development
Tianli Zheng - Culver City CA, US Chang Huang - Los Angeles CA, US
Assignee:
AmCyte, Inc. - Santa Monica CA
International Classification:
A61K045/00 C12N005/08
US Classification:
424/093700, 435/366000
Abstract:
This invention relates to the discovery that an intermediate, differentiated stage of pancreatic stem cells exist that can be propagated in a stable manner in successive serial passaging while maintaining insulin production in response to glucose. These cells are advantageous in that they are both expandable and stable in culture and can driven to late stage development, i.e. prototype islet cells. This invention further provides for culturing techniques that select for these intermediate differentiated stage cells and selectively eliminates early or late stage pancreatic cells.